primary human keratinocytes Search Results


99
ATCC normal human neonatal keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Normal Human Neonatal Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/Primary+Epidermal+Keratinocytes%3B+Normal%2C+Human%2C+Neonatal+Foreskin/pmc06754567-132-2-30
Average 99 stars, based on 1 article reviews
normal human neonatal keratinocytes - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
ATCC human skin keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Human Skin Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/Primary+Epidermal+Keratinocytes%3B+Normal%2C+Human%2C+Adult/pm32582096-90-14-18
Average 99 stars, based on 1 article reviews
human skin keratinocytes - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

94
ATCC product atcc pcs 200 010
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Product Atcc Pcs 200 010, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/Primary+Epidermal+Keratinocytes%3B+Normal%2C+Human%2C+Neonatal/us09655930-72-16-17
Average 94 stars, based on 1 article reviews
product atcc pcs 200 010 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
ATCC human epidermal keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Human Epidermal Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/Primary+Epidermal+Keratinocytes%3B+Normal%2C+Human%2C+Adult/us10562894-799-30-33
Average 95 stars, based on 1 article reviews
human epidermal keratinocytes - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
ATCC normal human gingival keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Normal Human Gingival Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/Primary+Gingival+Keratinocytes%3B+Normal%2C+Human/pmc12521062-73-0-13
Average 94 stars, based on 1 article reviews
normal human gingival keratinocytes - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
ScienCell human epidermal keratinocytes (heks)
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Human Epidermal Keratinocytes (Heks), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/human+primary+neonatal+keratinocytes/pm22609345-41-0-21
Average 90 stars, based on 1 article reviews
human epidermal keratinocytes (heks) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PELOBIOTECH GmbH primary human keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Primary Human Keratinocytes, supplied by PELOBIOTECH GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/primary+human+keratinocytes/pm37981221-48-34-39
Average 90 stars, based on 1 article reviews
primary human keratinocytes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CELLnTEC Advanced Cell Systems AG normal human keratinocytes hpek
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Normal Human Keratinocytes Hpek, supplied by CELLnTEC Advanced Cell Systems AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/human+primary+epidermal+keratinocytes+hpek+50/pm32949447-39-0-11
Average 90 stars, based on 1 article reviews
normal human keratinocytes hpek - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioWhittaker Molecular Applications human primary epidermal keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Human Primary Epidermal Keratinocytes, supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/human+primary+epidermal+keratinocytes/10__1111_slash_j__0022___202x__2004__22731__x-141-0-7
Average 90 stars, based on 1 article reviews
human primary epidermal keratinocytes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Kurabo industries cultured keratinocytes of human epidermis origin
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Cultured Keratinocytes Of Human Epidermis Origin, supplied by Kurabo industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/primary+human+keratinocytes/us07763263-160-9-13
Average 90 stars, based on 1 article reviews
cultured keratinocytes of human epidermis origin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
EXT Life Sciences Inc primary human keratinocytes
Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human <t>keratinocytes</t> were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.
Primary Human Keratinocytes, supplied by EXT Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/primary+human+keratinocytes/pm17369812-1123-9-35
Average 90 stars, based on 1 article reviews
primary human keratinocytes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
DS Pharma Biomedical human primary keratinocytes
( a ) Immunofluorescence labeling confocal microscopy to localize TSLPR and IL-7Rα in the area of epidermis where ΔNp63 was not detected. Bar = 20 µm. ( b , c ) Quantitative RT-PCR ( b ) and immunoblot analysis ( c ) against ΔNp63, TSLPR, IL-7Rα and TSLP in control siRNA (siControl) and p63-specific siRNA (sip63)-transfected HaCaT <t>keratinocytes.</t> β-actin was used as a loading control. The cells were harvested for assays at 72 hr after siRNA transfection. Student's t test. ** P <0.01 and N.S., not significant. ( d ) Immunofluorescence labeling fluorescence microscopy to localize TSLPR in siControl and sip63 HaCaT keratinocytes. The cells were fixed at 72 hr after siRNA introduction. DAPI, 4′,6-diamidino-2-phenylindole. Bar = 50 µm. Data are representative of at least three independent experiments.
Human Primary Keratinocytes, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+human+keratinocytes/human+primary+keratinocytes/pmc04149429-31-0-6
Average 90 stars, based on 1 article reviews
human primary keratinocytes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human keratinocytes were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.

Journal: Toxicology and applied pharmacology

Article Title: Monoubiquitinated γ-H2AX: abundant product and specific biomarker for non-apoptotic DNA double-strand breaks

doi: 10.1016/j.taap.2018.07.007

Figure Lengend Snippet: Panels A-C used antibodies #1. (A) Impact of gel polyacrylamide percentage and transfer conditions to PVDF membranes. Treatments of H460 cells: 6 h with 3 mM hydroxyurea (HU), 6 or 16 h with 5 μM aphidicolin (Aphi) or 1 h with 5 μM bleomycin (Bleo). All γ-H2AX images had 5 s film exposures. (B) Ethanol effect in semi-dry transfer. IMR90 cells were treated with 40 μM etoposide (Eto) for 1 h. (C) Comparison of wet (pH 8.2 and pH 8.8) and semi-dry transfers using 12% ethanol-containing buffers (10 s film exposures for all γ-H2AX images). IMR90 cells were treated with 40 μM etoposide for 1 h. (D) Effectiveness of different antibodies using semi-dry transfer with 12% ethanol. Normal human keratinocytes were treated for 1 h with 30 μM etoposide or 0.5 μM bleomycin. Antibodies #1–3: 1:1000 dilutions and 5 s exposures, antibody #4: 1:1000 dilution and 60 s exposure. (E) Comparison of antibodies #1 and #5 (both at 1:1000 dilutions) in H460 cells treated with bleomycin for 1 h. (F) γ-H2AX blot (Ab#1) in control and H2AX-depleted IMR90 cells treated with 100 μM etoposide for 1h.

Article Snippet: IMR90, WI38, normal human neonatal keratinocytes (PCS-200–010), H460, A549, U2OS, mouse embryonic fibroblasts (MEFs, SCRC-1040), telomerase-immortalized human bronchial epithelial HBEC3 (CRL-4051), Daudi, HCT116, Ramos, Raji and CA46 were obtained from ATCC.

Techniques: Comparison, Control

( a ) Immunofluorescence labeling confocal microscopy to localize TSLPR and IL-7Rα in the area of epidermis where ΔNp63 was not detected. Bar = 20 µm. ( b , c ) Quantitative RT-PCR ( b ) and immunoblot analysis ( c ) against ΔNp63, TSLPR, IL-7Rα and TSLP in control siRNA (siControl) and p63-specific siRNA (sip63)-transfected HaCaT keratinocytes. β-actin was used as a loading control. The cells were harvested for assays at 72 hr after siRNA transfection. Student's t test. ** P <0.01 and N.S., not significant. ( d ) Immunofluorescence labeling fluorescence microscopy to localize TSLPR in siControl and sip63 HaCaT keratinocytes. The cells were fixed at 72 hr after siRNA introduction. DAPI, 4′,6-diamidino-2-phenylindole. Bar = 50 µm. Data are representative of at least three independent experiments.

Journal: PLoS ONE

Article Title: ΔNp63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis

doi: 10.1371/journal.pone.0105498

Figure Lengend Snippet: ( a ) Immunofluorescence labeling confocal microscopy to localize TSLPR and IL-7Rα in the area of epidermis where ΔNp63 was not detected. Bar = 20 µm. ( b , c ) Quantitative RT-PCR ( b ) and immunoblot analysis ( c ) against ΔNp63, TSLPR, IL-7Rα and TSLP in control siRNA (siControl) and p63-specific siRNA (sip63)-transfected HaCaT keratinocytes. β-actin was used as a loading control. The cells were harvested for assays at 72 hr after siRNA transfection. Student's t test. ** P <0.01 and N.S., not significant. ( d ) Immunofluorescence labeling fluorescence microscopy to localize TSLPR in siControl and sip63 HaCaT keratinocytes. The cells were fixed at 72 hr after siRNA introduction. DAPI, 4′,6-diamidino-2-phenylindole. Bar = 50 µm. Data are representative of at least three independent experiments.

Article Snippet: Human primary keratinocytes were purchased from DS Pharma Biomedical (Tokyo, Japan) and cultured in a serum-free medium for human keratinocytes (DS Pharma Biomedical).

Techniques: Immunofluorescence, Labeling, Confocal Microscopy, Quantitative RT-PCR, Western Blot, Control, Transfection, Fluorescence, Microscopy

( a ) Quantitative RT-PCR demonstrating the levels of ΔNp63, p73, TSLP, TSLPR and IL-7Rα mRNAs at 24 hr after treatment with 25 µg/ml poly I:C. One-way ANOVA followed by Tukey's multiple-comparison test. *** P <0.005 and **** P <0.001 versus control. ( b ) Immunoblot analysis showing the level of ΔNp63 at different time course after treatment with 25 µg/ml poly I:C. ( c ) Phase-contrast microscopy demonstrating the morphological changes of primary keratinocytes at 24 hr after 25 µg/ml poly I:C treatment. Bar = 50 µm. Data are representative of three independent experiments.

Journal: PLoS ONE

Article Title: ΔNp63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis

doi: 10.1371/journal.pone.0105498

Figure Lengend Snippet: ( a ) Quantitative RT-PCR demonstrating the levels of ΔNp63, p73, TSLP, TSLPR and IL-7Rα mRNAs at 24 hr after treatment with 25 µg/ml poly I:C. One-way ANOVA followed by Tukey's multiple-comparison test. *** P <0.005 and **** P <0.001 versus control. ( b ) Immunoblot analysis showing the level of ΔNp63 at different time course after treatment with 25 µg/ml poly I:C. ( c ) Phase-contrast microscopy demonstrating the morphological changes of primary keratinocytes at 24 hr after 25 µg/ml poly I:C treatment. Bar = 50 µm. Data are representative of three independent experiments.

Article Snippet: Human primary keratinocytes were purchased from DS Pharma Biomedical (Tokyo, Japan) and cultured in a serum-free medium for human keratinocytes (DS Pharma Biomedical).

Techniques: Quantitative RT-PCR, Comparison, Control, Western Blot, Microscopy

( a, b ) Quantitative RT-PCR ( a ) and ELISA ( b ) demonstrate the level of endogenous TSLP at 24 hr ( a ) or 72 hr ( b ) after treatment with exogenous TSLP (1 or 10 ng/ml) under the condition of TLR3 stimulation (5 µg/ml poly I:C) in primary keratinocytes. ( c, d ) Quantitative RT-PCR ( c ) and ELISA ( d ) show the level of endogenous TSLP at 24 hr ( c ) or 72 hr ( d ) after stimulation with 10 µg/ml poly I:C and 10 ng/ml TSLP in siControl and sip63 HaCaT keratinocytes. ( e ) Quantitative RT-PCR confirming whether neutralization of TSLP inhibits the generation of TSLP under the condition of TLR3 stimulation (5 µg/ml poly I:C) in primary keratinocytes. One-way ANOVA followed by Tukey's multiple-comparison test. * P <0.05, *** P <0.005 and N.S., not significant. Data are representative of at least three independent experiments.

Journal: PLoS ONE

Article Title: ΔNp63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis

doi: 10.1371/journal.pone.0105498

Figure Lengend Snippet: ( a, b ) Quantitative RT-PCR ( a ) and ELISA ( b ) demonstrate the level of endogenous TSLP at 24 hr ( a ) or 72 hr ( b ) after treatment with exogenous TSLP (1 or 10 ng/ml) under the condition of TLR3 stimulation (5 µg/ml poly I:C) in primary keratinocytes. ( c, d ) Quantitative RT-PCR ( c ) and ELISA ( d ) show the level of endogenous TSLP at 24 hr ( c ) or 72 hr ( d ) after stimulation with 10 µg/ml poly I:C and 10 ng/ml TSLP in siControl and sip63 HaCaT keratinocytes. ( e ) Quantitative RT-PCR confirming whether neutralization of TSLP inhibits the generation of TSLP under the condition of TLR3 stimulation (5 µg/ml poly I:C) in primary keratinocytes. One-way ANOVA followed by Tukey's multiple-comparison test. * P <0.05, *** P <0.005 and N.S., not significant. Data are representative of at least three independent experiments.

Article Snippet: Human primary keratinocytes were purchased from DS Pharma Biomedical (Tokyo, Japan) and cultured in a serum-free medium for human keratinocytes (DS Pharma Biomedical).

Techniques: Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Neutralization, Comparison

( a ) Immunohistochemical staining of ΔNp63 in normal skin and skin lesions of AD and SLE. Consecutive sections of each condition were stained with hematoxylin and eosin (HE). Bar = 50 µm. ( b ) Level of ΔNp63 was classified into three categories depending on staining intensity, as indicated by ΔNp63 hi , ΔNp63 lo and ΔNp63 − . The dot plot represents ratios of ΔNp63 lo/- keratinocytes in normal skin (n = 3) and AD lesions (n = 10). ( c ) Quantitative RT-PCR demonstrating the levels of TSLP and ΔNp63 mRNAs in normal skin and AD lesions. Student's t test. * P <0.05 and **** P <0.001. Data are representative of at least three independent experiments.

Journal: PLoS ONE

Article Title: ΔNp63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis

doi: 10.1371/journal.pone.0105498

Figure Lengend Snippet: ( a ) Immunohistochemical staining of ΔNp63 in normal skin and skin lesions of AD and SLE. Consecutive sections of each condition were stained with hematoxylin and eosin (HE). Bar = 50 µm. ( b ) Level of ΔNp63 was classified into three categories depending on staining intensity, as indicated by ΔNp63 hi , ΔNp63 lo and ΔNp63 − . The dot plot represents ratios of ΔNp63 lo/- keratinocytes in normal skin (n = 3) and AD lesions (n = 10). ( c ) Quantitative RT-PCR demonstrating the levels of TSLP and ΔNp63 mRNAs in normal skin and AD lesions. Student's t test. * P <0.05 and **** P <0.001. Data are representative of at least three independent experiments.

Article Snippet: Human primary keratinocytes were purchased from DS Pharma Biomedical (Tokyo, Japan) and cultured in a serum-free medium for human keratinocytes (DS Pharma Biomedical).

Techniques: Immunohistochemical staining, Staining, Quantitative RT-PCR

AD lesions possess many ΔNp63 lo/- keratinocytes, which might be considered as a major source of TSLP. A potential TLR3 ligand such as damaged-cell-derived dsRNA suppresses the expression of ΔNp63, which eventually further upregulates TSLPR and IL-7Rα and augments the susceptibility to TSLP in ΔNp63 lo/- keratinocytes. Since TSLP itself can help ΔNp63 lo/- keratinocytes to produce endogenous TSLP under the condition of TLR3 stimulation, an autocrine and/or paracrine loop of TSLP are generated in ΔNp63 lo/- keratinocytes, leading to undesired inflammation of AD lesions.

Journal: PLoS ONE

Article Title: ΔNp63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis

doi: 10.1371/journal.pone.0105498

Figure Lengend Snippet: AD lesions possess many ΔNp63 lo/- keratinocytes, which might be considered as a major source of TSLP. A potential TLR3 ligand such as damaged-cell-derived dsRNA suppresses the expression of ΔNp63, which eventually further upregulates TSLPR and IL-7Rα and augments the susceptibility to TSLP in ΔNp63 lo/- keratinocytes. Since TSLP itself can help ΔNp63 lo/- keratinocytes to produce endogenous TSLP under the condition of TLR3 stimulation, an autocrine and/or paracrine loop of TSLP are generated in ΔNp63 lo/- keratinocytes, leading to undesired inflammation of AD lesions.

Article Snippet: Human primary keratinocytes were purchased from DS Pharma Biomedical (Tokyo, Japan) and cultured in a serum-free medium for human keratinocytes (DS Pharma Biomedical).

Techniques: Derivative Assay, Expressing, Generated